(SYNA) Synaptics - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US87157D1090
Stock: Semiconductors, Displays, Biometrics, Wireless, AI
Total Rating 42
Risk 85
Buy Signal -0.77
| Risk 5d forecast | |
|---|---|
| Volatility | 46.3% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.44 |
| Alpha | -21.06 |
| Character TTM | |
|---|---|
| Beta | 2.162 |
| Beta Downside | 2.727 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.18% |
| CAGR/Max DD | -0.19 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: SYNA Synaptics March 04, 2026
Synaptics Inc. designs and sells semiconductor products globally. The companys offerings span touch, display, biometrics, voice, audio, and wireless technologies.
Synaptics serves diverse markets including mobile, personal computers, smart home, industrial, and automotive sectors. Its business model involves selling through direct sales, representatives, OEM distributors, and value-added resellers. The semiconductor industry is characterized by high R&D investment and rapid technological cycles.
Synaptics provides specialized solutions like Natural ID for fingerprint recognition and DisplayLink for simplified external display connectivity. Such specialized components are crucial for differentiating end products in competitive markets.
For more detailed financial analysis and market comparisons, consider exploring ValueRay.
Headlines to watch out for
- Global semiconductor demand impacts revenue
- Wireless connectivity solutions drive growth
- Supply chain disruptions increase production costs
- Competition in AI/ML tools affects market share
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -61.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.53 > 1.0 |
| NWC/Revenue: 44.36% < 20% (prev 65.44%; Δ -21.09% < -1%) |
| CFO/TA 0.07 > 3% & CFO 190.6m > Net Income -61.9m |
| Net Debt (398.6m) to EBITDA (91.5m): 4.36 < 3 |
| Current Ratio: 2.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.9m) vs 12m ago -2.26% < -2% |
| Gross Margin: 43.13% > 18% (prev 0.46%; Δ 4.27k% > 0.5%) |
| Asset Turnover: 44.96% > 50% (prev 39.94%; Δ 5.01% > 0%) |
| Interest Coverage Ratio: -12.88 > 6 (EBITDA TTM 91.5m / Interest Expense TTM 5.60m) |
Altman Z'' 3.60
| A: 0.20 (Total Current Assets 771.0m - Total Current Liabilities 263.4m) / Total Assets 2.56b |
| B: 0.45 (Retained Earnings 1.15b / Total Assets 2.56b) |
| C: -0.03 (EBIT TTM -72.1m / Avg Total Assets 2.55b) |
| D: 0.98 (Book Value of Equity 1.15b / Total Liabilities 1.18b) |
| Altman-Z'' Score: 3.60 = AA |
Beneish M -3.07
| DSRI: 0.80 (Receivables 132.7m/146.5m, Revenue 1.14b/1.01b) |
| GMI: 1.07 (GM 43.13% / 46.24%) |
| AQI: 1.11 (AQ_t 0.67 / AQ_t-1 0.60) |
| SGI: 1.13 (Revenue 1.14b / 1.01b) |
| TATA: -0.10 (NI -61.9m - CFO 190.6m) / TA 2.56b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of SYNA shares?
As of March 19, 2026, the stock is trading at USD 74.56 with a total of 638,164 shares traded.
Over the past week, the price has changed by -5.62%, over one month by -14.63%, over three months by -1.76% and over the past year by +11.29%.
Over the past week, the price has changed by -5.62%, over one month by -14.63%, over three months by -1.76% and over the past year by +11.29%.
Is SYNA a buy, sell or hold?
Synaptics has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy SYNA.
- StrongBuy: 4
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SYNA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 102.2 | 37% |
| Analysts Target Price | 102.2 | 37% |
SYNA Fundamental Data Overview March 16, 2026
P/E Forward = 14.1243
P/S = 2.5168
P/B = 2.0678
P/EG = 0.5118
Revenue TTM = 1.14b USD
EBIT TTM = -72.1m USD
EBITDA TTM = 91.5m USD
Long Term Debt = 836.0m USD (from longTermDebt, last quarter)
Short Term Debt = 45.4m USD (from shortTermDebt, last fiscal year)
Debt = 836.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 398.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.28b USD (2.88b + Debt 836.0m - CCE 437.4m)
Interest Coverage Ratio = -12.88 (Ebit TTM -72.1m / Interest Expense TTM 5.60m)
EV/FCF = 22.64x (Enterprise Value 3.28b / FCF TTM 144.8m)
FCF Yield = 4.42% (FCF TTM 144.8m / Enterprise Value 3.28b)
FCF Margin = 12.65% (FCF TTM 144.8m / Revenue TTM 1.14b)
Net Margin = -5.41% (Net Income TTM -61.9m / Revenue TTM 1.14b)
Gross Margin = 43.13% ((Revenue TTM 1.14b - Cost of Revenue TTM 650.8m) / Revenue TTM)
Gross Margin QoQ = 43.54% (prev 42.60%)
Tobins Q-Ratio = 1.28 (Enterprise Value 3.28b / Total Assets 2.56b)
Interest Expense / Debt = 0.29% (Interest Expense 2.40m / Debt 836.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -57.0m (EBIT -72.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.93 (Total Current Assets 771.0m / Total Current Liabilities 263.4m)
Debt / Equity = 0.60 (Debt 836.0m / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 4.36 (Net Debt 398.6m / EBITDA 91.5m)
Debt / FCF = 2.75 (Net Debt 398.6m / FCF TTM 144.8m)
Total Stockholder Equity = 1.39b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.43% (Net Income -61.9m / Total Assets 2.56b)
RoE = -4.45% (Net Income TTM -61.9m / Total Stockholder Equity 1.39b)
RoCE = -3.24% (EBIT -72.1m / Capital Employed (Equity 1.39b + L.T.Debt 836.0m))
RoIC = -2.56% (negative operating profit) (NOPAT -57.0m / Invested Capital 2.23b)
WACC = 10.81% (E(2.88b)/V(3.72b) * Re(13.88%) + D(836.0m)/V(3.72b) * Rd(0.29%) * (1-Tc(0.21)))
Discount Rate = 13.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
[DCF] Terminal Value 58.73% ; FCFF base≈98.2m ; Y1≈64.5m ; Y5≈29.4m
[DCF] Fair Price = N/A (negative equity: EV 390.2m - Net Debt 398.6m = -8.40m; debt exceeds intrinsic value)
EPS Correlation: -47.30 | EPS CAGR: -26.04% | SUE: 0.03 | # QB: 0
Revenue Correlation: -58.28 | Revenue CAGR: -11.09% | SUE: 2.62 | # QB: 3
EPS current Year (2026-06-30): EPS=4.43 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+10 | Growth EPS=+22.5% | Growth Revenue=+10.6%
EPS next Year (2027-06-30): EPS=5.29 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+5 | Growth EPS=+19.3% | Growth Revenue=+10.6%
[Analyst] Revisions Ratio: +0.83 (11 Up / 1 Down within 30d for Current Year)
P/S = 2.5168
P/B = 2.0678
P/EG = 0.5118
Revenue TTM = 1.14b USD
EBIT TTM = -72.1m USD
EBITDA TTM = 91.5m USD
Long Term Debt = 836.0m USD (from longTermDebt, last quarter)
Short Term Debt = 45.4m USD (from shortTermDebt, last fiscal year)
Debt = 836.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 398.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.28b USD (2.88b + Debt 836.0m - CCE 437.4m)
Interest Coverage Ratio = -12.88 (Ebit TTM -72.1m / Interest Expense TTM 5.60m)
EV/FCF = 22.64x (Enterprise Value 3.28b / FCF TTM 144.8m)
FCF Yield = 4.42% (FCF TTM 144.8m / Enterprise Value 3.28b)
FCF Margin = 12.65% (FCF TTM 144.8m / Revenue TTM 1.14b)
Net Margin = -5.41% (Net Income TTM -61.9m / Revenue TTM 1.14b)
Gross Margin = 43.13% ((Revenue TTM 1.14b - Cost of Revenue TTM 650.8m) / Revenue TTM)
Gross Margin QoQ = 43.54% (prev 42.60%)
Tobins Q-Ratio = 1.28 (Enterprise Value 3.28b / Total Assets 2.56b)
Interest Expense / Debt = 0.29% (Interest Expense 2.40m / Debt 836.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -57.0m (EBIT -72.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.93 (Total Current Assets 771.0m / Total Current Liabilities 263.4m)
Debt / Equity = 0.60 (Debt 836.0m / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 4.36 (Net Debt 398.6m / EBITDA 91.5m)
Debt / FCF = 2.75 (Net Debt 398.6m / FCF TTM 144.8m)
Total Stockholder Equity = 1.39b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.43% (Net Income -61.9m / Total Assets 2.56b)
RoE = -4.45% (Net Income TTM -61.9m / Total Stockholder Equity 1.39b)
RoCE = -3.24% (EBIT -72.1m / Capital Employed (Equity 1.39b + L.T.Debt 836.0m))
RoIC = -2.56% (negative operating profit) (NOPAT -57.0m / Invested Capital 2.23b)
WACC = 10.81% (E(2.88b)/V(3.72b) * Re(13.88%) + D(836.0m)/V(3.72b) * Rd(0.29%) * (1-Tc(0.21)))
Discount Rate = 13.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
[DCF] Terminal Value 58.73% ; FCFF base≈98.2m ; Y1≈64.5m ; Y5≈29.4m
[DCF] Fair Price = N/A (negative equity: EV 390.2m - Net Debt 398.6m = -8.40m; debt exceeds intrinsic value)
EPS Correlation: -47.30 | EPS CAGR: -26.04% | SUE: 0.03 | # QB: 0
Revenue Correlation: -58.28 | Revenue CAGR: -11.09% | SUE: 2.62 | # QB: 3
EPS current Year (2026-06-30): EPS=4.43 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+10 | Growth EPS=+22.5% | Growth Revenue=+10.6%
EPS next Year (2027-06-30): EPS=5.29 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+5 | Growth EPS=+19.3% | Growth Revenue=+10.6%
[Analyst] Revisions Ratio: +0.83 (11 Up / 1 Down within 30d for Current Year)